These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1995995)

  • 1. Alternative immune globulin preparation when standard immune serum globulin is not available.
    Lutwick LI; Wu EH
    JAMA; 1991 Mar; 265(9):1114. PubMed ID: 1995995
    [No Abstract]   [Full Text] [Related]  

  • 2. Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next.
    Young MK; Cripps AW
    Hum Vaccin Immunother; 2013 Sep; 9(9):1885-93. PubMed ID: 23783220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles and immune globulin prophylaxis for travelers and hepatitis A.
    Wolfe MS
    Ann Intern Med; 1990 Feb; 112(3):235. PubMed ID: 2297200
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to hepatitis A virus in immune serum globulin.
    Smallwood LA; Tabor E; Finlayson JS; Gerety RJ
    Lancet; 1980 Aug; 2(8192):482-3. PubMed ID: 6106129
    [No Abstract]   [Full Text] [Related]  

  • 5. The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles.
    Young MK
    Hum Vaccin Immunother; 2019; 15(9):2060-2065. PubMed ID: 31116633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of immune serum globulin (ISG) against hepatitis A infection in a natural epidemic.
    Hall WT; Madden DL; Mundon FK; Brandt DE; Clarke NA
    Am J Epidemiol; 1977 Jul; 106(1):72-5. PubMed ID: 879162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of anti-hepatitis immunoglobulins on the intensity of the immunity to the hepatitis A virus].
    Perepelkin VS; Katkov AI; Semenenko TA; Mikhaĭlov MI; Vasil'eva VI
    Voen Med Zh; 1993 Feb; (2):37-8. PubMed ID: 8388594
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylaxis of hepatitis A with immune globulin.
    Braithwaite MG
    J R Army Med Corps; 1983 Jun; 129(2):88-92. PubMed ID: 6620245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBsAG-negative blood donors with a history of jaundice as a source of plasma for preparation of hyperimmune hepatitis type A globulin.
    Hopkins R
    J Infect; 1981 Jun; 3(2):166-71. PubMed ID: 7185957
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prophylactic effectiveness of immunoglobulin preparations with different amounts of specific antibodies to the hepatitis A virus].
    Perepelkin VS; Sumarokov AA; Gorbunov MA; Tiantov GA; Borzykh VA
    Voen Med Zh; 1988 Dec; (12):37-9. PubMed ID: 2853893
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidental asthma prevention by immune serum globulin.
    Mimouni D; Gdalevich M; Mimouni K; Mimouni FB; Eldad A; Shpilberg O
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):99-100. PubMed ID: 12141729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune serum globulin for protection against viral hepatitis. Condensed recommendations of the Public Health Service Advisory Committee on Immunization Practices.
    Clin Pediatr (Phila); 1973 Jan; 12(1):5 passim. PubMed ID: 4739169
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study.
    Lerman Y; Shohat T; Ashkenazi S; Almog R; Heering SL; Shemer J
    Clin Infect Dis; 1993 Sep; 17(3):411-4. PubMed ID: 8218682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of seroconversion following treatment with hepatitis B immune globulin containing antibody to human immunodeficiency virus.
    Phillips M; Cummins LM
    Hepatology; 1988; 8(3):497-8. PubMed ID: 3371869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic efficacy of immune serum globulin against hepatitis A.
    Ohara H; Ebisawa I; Ohtani S
    Jpn J Exp Med; 1986 Oct; 56(5):229-33. PubMed ID: 3027432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statement on immunizing agents for the prevention of hepatitis.
    CMAJ; 1985 Sep; 133(6):581-5. PubMed ID: 3161607
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure.
    Young MK; Ng SK; Nimmo GR; Cripps AW
    Expert Opin Drug Metab Toxicol; 2020 Jul; 16(7):641-644. PubMed ID: 32362179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Dec; 45(RR-15):1-30. PubMed ID: 9005304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune globulin and serologic tests for hepatitis A.
    Gustafson TL; Sehulster LM
    J Infect Dis; 1983 Aug; 148(2):360-1. PubMed ID: 6886497
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of human immune serum globulin on infectivity of hepatitis A virus.
    Krugman S
    J Infect Dis; 1976 Jul; 134(1):70-4. PubMed ID: 181498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.